MENU
MNPR
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Monopar Therapeutics (MNPR) Ownership - Who owns Monopar Therapeutics?
Profile
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.64M
P/E Ratio
N/A
Total Cash
7.12M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash/Share
2.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MNPR
Capitalization
23.6M
P/E Ratio
N/A
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash
7.12M
Total Cash/Share
2.02
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.09M
P/B Ratio
3.88
Cash Flow
N/A
Earnings
-2.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.6K
Current Ratio
6.59
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-81.33
Shares Held By Institutions
308K
Shares Outstanding - Current
3.52M
Total Liabilities
1.09M
Total Volume MTD
N/A
Value
N/A
Gain YTD
209.230
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
10
Web
https://www.monopartx.com